- Home
- WKHS vs INKT Comparison
WKHS vs INKT Comparison
Compare WKHS & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKHS
- INKT
- Stock Information
- Founded
- WKHS 2007
- INKT 2017
- Country
- WKHS United States
- INKT United States
- Employees
- WKHS N/A
- INKT N/A
- Industry
- WKHS Auto Manufacturing
- INKT Medicinal Chemicals and Botanical Products
- Sector
- WKHS Consumer Discretionary
- INKT Health Care
- Exchange
- WKHS Nasdaq
- INKT Nasdaq
- Market Cap
- WKHS 6.0M
- INKT 28.8M
- IPO Year
- WKHS N/A
- INKT 2021
- Fundamental
- Price
- WKHS $4.42
- INKT $62.86
- Analyst Decision
- WKHS Hold
- INKT Strong Buy
- Analyst Count
- WKHS 1
- INKT 2
- Target Price
- WKHS $15.62
- INKT $37.50
- AVG Volume (30 Days)
- WKHS 6.6M
- INKT 2.4M
- Earning Date
- WKHS 08-19-2025
- INKT 08-12-2025
- Dividend Yield
- WKHS N/A
- INKT N/A
- EPS Growth
- WKHS N/A
- INKT N/A
- EPS
- WKHS N/A
- INKT N/A
- Revenue
- WKHS $5,917,985.00
- INKT N/A
- Revenue This Year
- WKHS $54.16
- INKT N/A
- Revenue Next Year
- WKHS $85.00
- INKT N/A
- P/E Ratio
- WKHS N/A
- INKT N/A
- Revenue Growth
- WKHS N/A
- INKT N/A
- 52 Week Low
- WKHS $0.81
- INKT $4.56
- 52 Week High
- WKHS $28.13
- INKT $76.00
- Technical
- Relative Strength Index (RSI)
- WKHS 95.23
- INKT 57.39
- Support Level
- WKHS $2.52
- INKT $6.80
- Resistance Level
- WKHS $3.89
- INKT $7.88
- Average True Range (ATR)
- WKHS 0.53
- INKT 0.40
- MACD
- WKHS 0.31
- INKT 0.02
- Stochastic Oscillator
- WKHS 74.57
- INKT 58.86
About WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.